本文選題：乳腺癌 + 剪切波彈性成像　； 參考：《山西醫(yī)科大學(xué)》2017年碩士論文

【摘要】：目的:應(yīng)用實(shí)時(shí)剪切波彈性成像(Shear-wave elastography,SWE)技術(shù)分析乳腺癌腫塊彈性模量最大值Emax與腫塊大小、組織分級(jí)、免疫組化指標(biāo)雌激素受體(ER)、孕激素受體(PR)、人類(lèi)表皮生長(zhǎng)因子受體2(C-erbB-2)、Ki-67表達(dá)情況及分子分型之間的關(guān)系,尋求一個(gè)可以評(píng)價(jià)乳腺癌生物學(xué)行為的新指標(biāo),為乳腺癌治療策略的選擇及預(yù)后判斷提供一定的參考依據(jù)。方法:選擇經(jīng)病理證實(shí)的乳腺癌患者160例(乳腺癌病灶171個(gè)),年齡28-75歲,平均(53.8±19.3)歲。術(shù)前均行常規(guī)超聲及SWE檢查,SWE模式下測(cè)量彈性模量最大值Emax,同一病灶重復(fù)測(cè)量3次,取平均值;二維聲像圖下分別測(cè)量腫塊的左右徑、上下徑、前后徑,取其中最大的徑線,將其分為10mm、10-20mm、20mm三組;術(shù)后根據(jù)病理結(jié)果記錄腫塊的組織分級(jí)、免疫組化ER、PR、C-erbB-2、Ki-67表達(dá)情況及分子分型情況。比較不同大小、不同組織分級(jí)腫塊的Emax值的差異;比較免疫組化ER、PR、C-erbB-2、Ki-67表達(dá)陽(yáng)性與陰性者的Emax值的差異;比較不同分子分型間的Emax值的差異;將差異顯著的變量納入多元線性回歸分析,由偏回歸系數(shù)確定各指標(biāo)貢獻(xiàn)程度,評(píng)估對(duì)Emax值影響最大的因素。結(jié)果:1.腫塊大小與腫塊彈性模量最大值Emax呈顯著正相關(guān),腫塊體積大者Emax值大于體積小者(rs=0.510,P0.05),Emax值較大者擁有較大的腫塊大小。2.C-erbB-2、Ki-67陽(yáng)性表達(dá)者與陰性表達(dá)者Emax值存在顯著差異,C-erbB-2、Ki-67陽(yáng)性表達(dá)者腫塊Emax值大于陰性表達(dá)者(t=-3.269、-2.079,P均0.05)。3.不同分子亞型的腫塊間彈性模量最大值Emax值差異顯著(P0.05),其中HER-2陽(yáng)性型腫塊的Emax值最大,其次順序?yàn)長(zhǎng)uminal B型、TN型、Luminal A型。分別將不同分子亞型腫塊的Emax值兩兩比較,Luminal B型與TN型差異無(wú)統(tǒng)計(jì)學(xué)意義(P0.05),余各型腫塊Emax值兩兩比較差異均具有統(tǒng)計(jì)學(xué)意義(P0.05)。4.多元回歸方程的調(diào)整后絕對(duì)系數(shù)Adjust R2=0.306(F=38.446,P0.05),腫塊大小和C-erbB-2表達(dá)情況可以解釋Emax值變異的30.6%,二者偏回歸系數(shù)分別為:0.500、0.237(P均0.05),腫瘤大小、C-erbB-2對(duì)腫物硬度影響最大。結(jié)論:1.乳腺癌腫塊大小和C-erbB-2、Ki-67表達(dá)情況對(duì)腫塊彈性模量最大值Emax有一定的影響,其中腫塊大小和C-erbB-2對(duì)Emax值的影響程度最大。2.不同分子亞型腫塊間Emax值不同,HER-2陽(yáng)性型腫塊Emax值最大,其后依次為luminal B型、TN型、luminal A型,預(yù)后差的乳腺癌腫塊往往具有較高的Emax值。3.Emax可以在一定程度上反映乳腺癌的生物學(xué)特性,SWE可能成為一個(gè)新的手段,為乳腺癌的預(yù)后判斷及治療方案的選擇提供一定的依據(jù)。
[Abstract]:Objective: to analyze the maximum modulus of elasticity (Emax), tumor size and tissue grade of breast cancer by using Shear-wave elastography technique. The expression of estrogen receptor ERA, progesterone receptor PRA, human epidermal growth factor receptor 2C-erbB-2 and Ki-67 and their molecular typing were studied in order to find a new index to evaluate the biological behavior of breast cancer. To provide a certain reference for breast cancer treatment strategy selection and prognosis judgment. Methods: a total of 160 patients with breast cancer (171 breast cancer lesions aged 28-75 years, mean 53.8 鹵19.3 years) were selected. The maximum modulus of elasticity (Emaxmax) was measured by conventional ultrasound and SWE before operation, the same lesion was measured 3 times, the mean value was taken, and the diameter of left and right, upper and lower diameters, anteroposterior diameters of the masses were measured under two-dimensional sonogram, and the largest diameter was taken. They were divided into three groups: 10 mm 10 ~ 20 mm ~ 20 mm, the histological grade of the tumor was recorded according to the pathological results, the expression of C-erbB-2 Ki-67 and the molecular type of the tumor were observed by immunohistochemistry. The difference of Emax value in different tissue grade tumor, the difference of Emax value between positive and negative expression of C-erbB-2Ki-67 in ERT were compared, and the difference of Emax value among different molecular types was also compared. The variable with significant difference was incorporated into the multivariate linear regression analysis, and the contribution degree of each index was determined by partial regression coefficient, and the factors that had the greatest influence on Emax value were evaluated. The result is 1: 1. There was a significant positive correlation between the tumor size and the maximum modulus of elasticity (Emax). There was significant difference in Emax value between the positive expression of C-erbB-2Ki-67 and the negative expression in the Emax value of the large tumor than that in the small one (P < 0.05). There was significant difference between the positive expression of C-erbB-2Ki-67 and the Emax value of the negative expression. The Emax value of the tumor with the positive expression of C-erbB-2Ki-67 was higher than that of the negative expression (P < 0.05). There was significant difference in the maximum Emax value of elastic modulus among the different molecular subtypes. The Emax value of HER-2 positive tumor was the largest, followed by Luminal B type TN and Luminal A type. There was no significant difference in Emax value between luminal B type and TN type, but there was significant difference in Emax value of other types of tumor. The absolute coefficient of the multivariate regression equation, Adjust R2O 0.306FU 38.446, P0.05A, the tumor size and the expression of C-erbB-2 can explain the variation of Emax value. The partial regression coefficients of the two regression equations are respectively 0. 05 and 0. 05%, and the size of tumor C-erbB-2 has the greatest effect on the hardness of the tumor. Conclusion 1. The tumor size and the expression of C-erbB-2Ki-67 in breast cancer had a certain influence on the maximum modulus of elasticity (Emax), in which the tumor size and C-erbB-2 had the greatest influence on the Emax value. The Emax value of HER-2 positive tumors was the highest among different molecular subtypes, followed by luminal B type TN and luminal A type. Breast cancer masses with poor prognosis often have higher Emax value. 3. Emax can reflect the biological characteristics of breast cancer to some extent. It may become a new method for judging the prognosis of breast cancer and the choice of treatment plan.
【學(xué)位授予單位】：山西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R737.9;R445.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 史春穎;劉源;李睿;陳穎;楊予川;李丹陽(yáng);;乳腺導(dǎo)管原位癌的發(fā)病危險(xiǎn)因素及生物學(xué)指標(biāo)ER、PR、C-erbB-2表達(dá)的研究[J];哈爾濱醫(yī)科大學(xué)學(xué)報(bào);2015年01期

2 曹華;閆茂生;鄭濤;許瑞蓮;陳亦欣;王樹(shù)濱;劉雅潔;;乳腺癌分子分型的臨床意義[J];中華乳腺病雜志(電子版);2011年06期

3 田麗元;陳東風(fēng);曹長(zhǎng)軍;王少春;;乳腺癌超聲表現(xiàn)與分子生物學(xué)指標(biāo)的相關(guān)性研究[J];中國(guó)醫(yī)學(xué)影像學(xué)雜志;2011年06期

4 李靖華;王曉春;楊季紅;;雄激素受體與乳腺癌關(guān)系的研究進(jìn)展[J];河北醫(yī)藥;2011年02期

5 劉旭霞;肖可;;深圳市羅湖區(qū)惡性腫瘤監(jiān)測(cè)資料分析[J];吉林醫(yī)學(xué);2009年19期

6 吳克雄;朱海鵬;;1224例惡性腫瘤病人構(gòu)成分析[J];新疆醫(yī)學(xué);2008年10期

7 張嫣;郭慶祿;張江宇;葉志球;魏北陽(yáng);馮長(zhǎng)征;劉永熙;;乳腺癌鉬靶X線表現(xiàn)與p53表達(dá)的相關(guān)性探討[J];廣州醫(yī)藥;2007年01期

8 王怡,王涌,張希敏,秦茜淼,王意達(dá),徐智章;組織彈性成像鑒別乳腺良惡性腫塊的價(jià)值評(píng)估[J];中國(guó)醫(yī)學(xué)影像技術(shù);2005年11期

相關(guān)碩士學(xué)位論文 前1條

1 鄢天偉;乳腺癌超聲彈性成像與ER、PR及C-erbB-2表達(dá)的相關(guān)性研究[D];遵義醫(yī)學(xué)院;2011年

，

本文編號(hào)：1794485